ZHI Mengjia 1 , DIAO Yifan 1 , LIU Shiyang 1 , HUANG Zhiran 1 , SU Xiawen 1 , GENG Shuai 2 , SUN Jing 1 , LIU Yuanli 1
  • 1. School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, P.R.China;
  • 2. Beijing 306 Hospital, Beijing, 100101, P.R.China;
SUN Jing, Email: sunjing@sph.pumc.edu.cn
Sufentanil; Fentanyl; Cesarean section; Patient-controlled intravenous analgesia; Meta-analysis; RCT
10.7507/1672-2531.201808005
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objectives To systematically review the efficacy and safety of sufentanil versus fentanyl used in patient-controlled intravenous analgesia (PCIA) after cesarean section.Methods An online search of computerized searches of the database of MEDLINE (OVID), Web of Science, The Cochrane Central Register of Controlled Trials, PubMed, EMbase, CNKI, WanFang Data, VIP and SinoMed were conducted. Randomized controlled trials published since the inceptions of these databases until April 1st 2018, involving the comparison of sufentanil versus fentanyl for PCIA after cesarean section were included. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was conducted using the RevMan 5.1 software.Results A total of 19 studies were included. The results of meta-analysis showed that, compared with the fentanyl group, the sufentanil group had statistically significant lower VAS scores at 4-hour (MD=–0.99, 95%CI –1.03 to –0.95, P<0.001), 8-hour (MD=–0.30, 95%CI –0.40 to –0.21, P<0.001), 12-hour (MD=–0.54, 95%CI –0.62 to –0.46, P<0.001) and 24-hour (MD=–0.35, 95%CI –0.41 to –0.28, P<0.001); statistically significant higher Ramsay scores at 4-hour (MD=0.72, 95%CI 0.66 to 0.78, P<0.001), 8-hour (MD=0.93, 95%CI 0.86 to 1.00, P<0.001), 12-hour (MD=0.98, 95%CI 0.91 to 1.05, P<0.001), 24-hour (MD=0.07, 95%CI 0.03 to 0.11, P=0.000 5), 48-hour (MD=0.05, 95%CI 0.03 to 0.08, P<0.000 1). As for the adverse reactions, sufentanil group had lower risks of having nausea and vomiting (RR=0.25, 95%CI 0.19 to 0.31, P<0.001), pruritus (RR=0.41, 95%CI 0.30 to 0.57, P<0.001), dizziness (RR=0.27, 95%CI 0.17 to 0.44, P<0.001) and urinary retention (RR=0.35, 95%CI (0.15, 0.82), P=0.02).Conclusions The current evidence shows that, sufentanil has better analgesia and sedative effects, and less risks of adverse reactions for safer clinical use.

Citation： ZHI Mengjia, DIAO Yifan, LIU Shiyang, HUANG Zhiran, SU Xiawen, GENG Shuai, SUN Jing, LIU Yuanli. Efficacy and safety of sufentanil versus fentanyl for patient-controlled intravenous analgesia after cesarean section: a systematic review. Chinese Journal of Evidence-Based Medicine, 2019, 19(3): 324-330. doi: 10.7507/1672-2531.201808005 Copy

  • Previous Article

    Efficacy and safety of local endometrial mechanical stimulation in patients with recurrent embryo implantation failure: a systematic review

  • Next Article

    Efficacy and safety of tranexamic acid in orthopaedic trauma surgery: a meta-analysis